The Canada IoT Medical Devices Market was valued at $1851 Million in 2025 and projected to reach to $3565.6 Million by 2030, representing a compound annual growth rate of 14.0%. Canada's IoT medical devices market is positioned for sustained growth through 2030, driven by an aging population requiring continuous health monitoring and chronic disease management solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada's IoT medical devices market is valued at $1,851.0 million in 2025, with projections reaching $3,565.6 million by 2030, representing a robust 14.0% CAGR driven by healthcare digitalization initiatives.
Canada's demographic shift toward an aging population is accelerating demand for remote monitoring and connected health solutions, particularly in chronic disease management and elderly care applications.
Strong Canadian healthcare infrastructure and government support for digital health initiatives create favorable conditions for IoT medical device adoption across hospitals, clinics, and home care settings.
Health Canada's streamlined approval processes and alignment with international standards facilitate faster market entry for innovative IoT medical devices, supporting sustained market expansion.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MULTIPARAMETER MONITORS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 18.9% from 2025 to 2030 |
| Largest Segment | HOSPITALS & CLINICS (End User) |
| Market Size Base Year (Billions) | ~USD 65.12 (2025) |
| Revenue Forecast (Billions) | ~USD 154.74 (2030) |
| Segments Covered | Product, Type, Connectivity Technology, End User |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems & Devices,Monitoring & Enterprise Informatics, |
| ABBOTT | United States | Public Company | Diagnostic Products,Medical Devices,Nutritional Products, |
| BOSTON SCIENTIFIC CORPORATION | United States | Public Company | Cardiovascular (structural heart, CRM, electrophysiology, peripheral interventions, oncology-related),MedSurg – Endoscopy (GI, pancreaticobiliary, single-use scopes, infection prevention),MedSurg – Urology and Pelvic Health, |
| OMRON CORPORATION | Japan | Public Company | Industrial Automation Systems and Components,Device and Module Solutions (Relays, Switches, Connectors, Sensors),Social Systems and Data/Power Solutions, |
| BAXTER INTERNATIONAL, INC. | United States | Public Company | Medical Products & Therapies (IV, infusion, parenteral nutrition, renal-related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment),Pharmaceuticals (generic injectables, specialty injectables, inhaled anesthetics, compounding), |
| JOHNSON & JOHNSON | United States | Public Company | Oncology & Immunology (Innovative Medicine),Neuroscience, Cardiovascular & Metabolism, Pulmonary Hypertension, Infectious Disease,Surgery & Interventional (including energy, stapling, wound closure, biosurgery), |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors & clinical information systems,Physiological measuring & neuro-diagnostics,Defibrillators, AEDs & therapeutic devices, |
| HONEYWELL INTERNATIONAL, INC. | United States | Public Company | Industrial Automation (control, instrumentation, smart energy, sensing, PPE, software and analytics),Building Automation (BMS software, controls, security, fire, services),Energy and Sustainability Solutions / UOP (licensed process technology, equipment, catalysts, software), |
| DRÄGERWERK AG & CO. KGAA | Germany | Public Company | Medical ventilators, anaesthesia, and lung monitoring,Patient monitoring and hospital infrastructure,Neonatal care and perinatal medicine, |
Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating in healthcare, lighting, and consumer electronics.
Abbott is a United States-based public company founded in 1888 with 115,000 employees, specializing in pharmaceuticals, diagnostics, and nutritional products.
Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, manufacturing medical devices for various therapeutic areas.
Omron Corporation is a Japanese public company founded in 1933 with 26,050 employees, specializing in automation, healthcare, and electronic components.
Baxter International, Inc. is a United States-based public company founded in 1931 with 37,500 employees, providing renal care, hospital products, and biopharmaceuticals.
Johnson & Johnson is a United States-based public company founded in 1886 with 138,200 employees, operating in pharmaceuticals, medical devices, and consumer health.
Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, manufacturing patient monitoring and diagnostic medical equipment.
Honeywell International, Inc. is a United States-based public company founded in 1885 with 101,000 employees, operating in aerospace, building technologies, and industrial solutions.
Drägerwerk AG & Co. KGaA is a German public company founded in 1889 with 16,033 employees, specializing in medical and safety technology.
Canada's IoT medical devices market is valued at $1,851.0 million in 2025 and is projected to reach $3,565.6 million by 2030.
Canada's IoT medical devices market is growing at a compound annual growth rate (CAGR) of 14.0% from 2025 to 2030.
Canada's market growth is driven by an aging population, rising chronic disease prevalence, strong healthcare infrastructure, government digitalization initiatives, and increasing adoption of remote monitoring technologies.
Canada shows strong adoption of remote patient monitoring devices, wearable health trackers, smart diagnostic equipment, and cloud-connected medical sensors across hospitals and home care settings.
Canada represents a significant portion of the North American IoT medical devices market, with advanced regulatory frameworks and healthcare investments supporting faster adoption than many global markets.
The study included several key activities aimed at estimating the current size of the IoT medical devices market. Extensive secondary research was conducted to collect information about this market. The next step involved validating the findings, assumptions, and size estimates by consulting industry experts from across the value chain through primary research. A combination of top-down and bottom-up approaches was used to estimate the overall market size. Subsequently, market segmentation and data triangulation techniques were applied to determine the sizes of specific segments and subsegments within the IoT medical devices market.
This research study extensively utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva. It also incorporated white papers, annual reports, companies' house documents, investor presentations, and SEC filings of various companies. The market for companies offering IoT medical device solutions was assessed using data from both, paid and free sources. This involved analyzing the product portfolios of major industry players and evaluating these companies based on their performance and quality. Various resources were employed during the secondary research process to gather relevant information for this study. These sources included annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, as well as directories and databases.
The secondary research process involved consulting a variety of sources to gather information relevant to the study. These sources included annual reports, press releases, investor presentations from IoT medical device vendors, forums, certified publications, and white papers. This research was essential for obtaining critical insights into the industry's value chain, identifying key players in the market, and understanding market classification and segmentation from both, market and technology-oriented perspectives.
In the primary research process, various sources from both, the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources mainly include industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations linked to all segments of the industry's value chain.
In-depth interviews were conducted with key industry participants, subject-matter experts (SMEs), C-level executives from leading market players, and industry consultants. This approach helped in gathering and verifying critical qualitative and quantitative information while also assessing future prospects.
The primary research aimed to identify different segmentation types, industry trends, key players, and important market dynamics, such as drivers, restraints, opportunities, challenges, and strategies adopted by major players in the industry.
After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis.
In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.
Breakdown of Primary Respondents
Note 1: Others include sales, marketing, and product managers.
Note 2: Tiers are defined based on a company's total revenue. As of 2023: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and the top-down approach (assessment of utilization/adoption/penetration trends by product, type, connectivity technology, end user, and region).

After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both, the demand and supply sides in the IoT medical devices market.
The IoT medical devices market refers to connected healthcare devices that use sensors and internet technology to gather and share patient data in real time. These tools support remote monitoring, individualized treatment, and better health outcomes across hospitals, clinics, and home care settings. Growth is fueled by the rise in chronic conditions, increased use of telemedicine, and innovations in wireless communication, though concerns around data privacy and regulatory standards remain key challenges.
Full forecast, segment splits, and company analysis for all IoT Medical Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report